Dr Alice Grey

Drug Allergy Stream PhD Scholar

  • PhD Candidate, University of Sydney
  • Project: Improving in vitro assays for diagnosing drug allergy​
  • Primary Supervisor: Associate Professor Stephen Adelstein, NACE Drug Allergy Stream member
  • Staff Specialist Immunologist, Network Director of Physician Training, Royal Prince Alfred Hospital

 Why is this research important to you personally, and those living with drug allergy? 

As a clinical immunologist caring for individuals with drug allergies, I have seen the harm that medication allergy and incorrect labelling of medication allergy can cause. The existing tests we have to diagnose drug allergy are imperfect and can carry significant risk to patients. I am hopeful that my research will find a more accurate and safer way to diagnose medication allergy, allowing patients to receive the treatment they need. 

What inspired you to pursue a career in allergy research?

I am passionate about translational research and was inspired to pursue a career in allergy research by my work as a clinician, which has allowed me to understand the significant impact of allergy on individuals and their families. Allergic disease is extremely common and causes substantial morbidity, yet still lacks adequate diagnostic tests and treatment options. I feel privileged to have the opportunity to contribute to the development of knowledge in this important field, and am very grateful to the NACE for their support.


Twitter: @ausimmdoc 


A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. Jun 2021

A single dose, BCG-adjuvanted SARS-CoV-2 vaccine induces Th1-polarized immunity and high-titre neutralizing antibodies in mice. Nature Partner Journals (Vaccines).  2021 Nov

Dupilumab in the treatment of asthma. Immunotherapy. Jun 2019

Stay informed 

Sign up for NACE news and allergy study updates


Become a member 

Are you part of the Australian and New Zealand allergy research community?

Join us

Proudly in partnership with the National Allergy Council and allergy organisations